Stryker (NYSE:SYK) updated its second quarter 2019 earnings guidance on Tuesday. The company provided EPS guidance of $1.90-1.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.96. Stryker also updated its FY 2019 guidance to $8.05-8.20 EPS.

Several equities analysts have weighed in on the company. ValuEngine lowered Stryker from a buy rating to a hold rating in a research note on Thursday, April 18th. Barclays increased their target price on Stryker from $203.00 to $211.00 and gave the company an overweight rating in a research note on Monday, April 15th. Zacks Investment Research lowered Stryker from a buy rating to a hold rating in a research note on Friday, April 12th. Wells Fargo & Co increased their target price on Stryker from $214.00 to $219.00 and gave the company an outperform rating in a research note on Monday, April 1st. Finally, JPMorgan Chase & Co. increased their target price on Stryker from $200.00 to $215.00 and gave the company an overweight rating in a research note on Tuesday, March 19th. Nine investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has an average rating of Buy and an average price target of $192.13.

Shares of NYSE SYK traded up $4.80 during mid-day trading on Tuesday, reaching $186.96. 2,754,379 shares of the company’s stock were exchanged, compared to its average volume of 1,434,516. The firm has a market cap of $67.26 billion, a P/E ratio of 25.58, a P/E/G ratio of 2.19 and a beta of 0.88. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.02 and a quick ratio of 1.41. Stryker has a twelve month low of $144.75 and a twelve month high of $199.85.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 29th. The medical technology company reported $2.18 EPS for the quarter, topping the Zacks’ consensus estimate of $2.15 by $0.03. The company had revenue of $3.80 billion for the quarter, compared to analyst estimates of $3.73 billion. Stryker had a return on equity of 27.60% and a net margin of 26.12%. Equities analysts anticipate that Stryker will post 8.13 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Thursday, March 28th. Stryker’s dividend payout ratio is presently 28.45%.

In related news, insider Timothy J. Scannell sold 4,666 shares of Stryker stock in a transaction that occurred on Tuesday, April 16th. The stock was sold at an average price of $192.40, for a total value of $897,738.40. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, VP M Kathryn Fink sold 180 shares of Stryker stock in a transaction that occurred on Monday, February 4th. The shares were sold at an average price of $176.77, for a total value of $31,818.60. The disclosure for this sale can be found here. In the last three months, insiders sold 130,455 shares of company stock worth $24,723,292. 7.20% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/stryker-syk-issues-q2-2019-earnings-guidance/2982873.html.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Read More: Options Trading – Understanding Strike Price

Earnings History and Estimates for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.